Employee-related Liabilities, Current in USD of Freeline Therapeutics Holdings plc from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Freeline Therapeutics Holdings plc quarterly Employee-related Liabilities, Current history and change rate from Q4 2019 to Q3 2023.
  • Freeline Therapeutics Holdings plc Employee-related Liabilities, Current for the quarter ending 30 Sep 2023 was $2.74M, a 31.3% decline year-over-year.
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Change (%)

Freeline Therapeutics Holdings plc Quarterly Employee-related Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $2.74M -$1.25M -31.3% 30 Sep 2023 6-K 01 Dec 2023
Q2 2023 $2.43M -$934K -27.8% 30 Jun 2023 6-K 15 Aug 2023
Q1 2023 $2.49M -$915K -26.9% 31 Mar 2023 6-K 30 May 2023
Q4 2022 $4.18M -$376K -8.26% 31 Dec 2022 6-K 01 Dec 2023
Q3 2022 $3.99M -$1.26M -24% 30 Sep 2022 6-K 15 Nov 2022
Q2 2022 $3.36M -$728K -17.8% 30 Jun 2022 6-K 09 Aug 2022
Q1 2022 $3.41M +$220K +6.91% 31 Mar 2022 6-K 10 May 2022
Q4 2021 $4.55M -$246K -5.13% 31 Dec 2021 20-F 04 Apr 2023
Q3 2021 $5.25M 30 Sep 2021 6-K 09 Nov 2021
Q2 2021 $4.09M +$2.19M +115% 30 Jun 2021 6-K 16 Aug 2021
Q1 2021 $3.19M 31 Mar 2021 6-K 17 May 2021
Q4 2020 $4.8M +$2.38M +98.4% 31 Dec 2020 20-F 31 Mar 2022
Q2 2020 $1.9M 30 Jun 2020 6-K 29 Oct 2020
Q4 2019 $2.42M 31 Dec 2019 20-F 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.